FR2881957B1 - Comprimes comprenant une substance biologiquement active et un excipient - Google Patents

Comprimes comprenant une substance biologiquement active et un excipient

Info

Publication number
FR2881957B1
FR2881957B1 FR0501580A FR0501580A FR2881957B1 FR 2881957 B1 FR2881957 B1 FR 2881957B1 FR 0501580 A FR0501580 A FR 0501580A FR 0501580 A FR0501580 A FR 0501580A FR 2881957 B1 FR2881957 B1 FR 2881957B1
Authority
FR
France
Prior art keywords
excipient
tablets
active substance
biologically active
biologically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0501580A
Other languages
English (en)
Other versions
FR2881957A1 (fr
Inventor
Karine Cavalier
Didier Sy
Roberto Rosa
Bernard Bataille
Michele Delalonde
Gilles Baylac
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Solvay SA
Original Assignee
Solvay SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0501580A priority Critical patent/FR2881957B1/fr
Application filed by Solvay SA filed Critical Solvay SA
Priority to US11/816,326 priority patent/US7892576B2/en
Priority to PCT/EP2006/050886 priority patent/WO2006087312A1/fr
Priority to JP2007555585A priority patent/JP2008530175A/ja
Priority to EP06708225A priority patent/EP1853236A1/fr
Priority to TW095104945A priority patent/TW200640442A/zh
Priority to ARP060100565A priority patent/AR056268A1/es
Publication of FR2881957A1 publication Critical patent/FR2881957A1/fr
Application granted granted Critical
Publication of FR2881957B1 publication Critical patent/FR2881957B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
FR0501580A 2005-02-16 2005-02-16 Comprimes comprenant une substance biologiquement active et un excipient Expired - Fee Related FR2881957B1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR0501580A FR2881957B1 (fr) 2005-02-16 2005-02-16 Comprimes comprenant une substance biologiquement active et un excipient
PCT/EP2006/050886 WO2006087312A1 (fr) 2005-02-16 2006-02-13 Comprimes contenant un principe biologiquement actif, et un excipient contenant du carbonate de calcium
JP2007555585A JP2008530175A (ja) 2005-02-16 2006-02-13 生物学的活性物質と、炭酸カルシウム含有賦形剤とを含む錠剤
EP06708225A EP1853236A1 (fr) 2005-02-16 2006-02-13 Comprimes contenant un principe biologiquement actif, et un excipient contenant du carbonate de calcium
US11/816,326 US7892576B2 (en) 2005-02-16 2006-02-13 Tablets comprising a biologically active substance and an excipient containing calcium carbonate
TW095104945A TW200640442A (en) 2005-02-16 2006-02-14 Tablets comprising a biologically active substance and an excipient
ARP060100565A AR056268A1 (es) 2005-02-16 2006-02-16 Tabletas que comprenden una sustancia biologicamente activa y un excipiente

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0501580A FR2881957B1 (fr) 2005-02-16 2005-02-16 Comprimes comprenant une substance biologiquement active et un excipient

Publications (2)

Publication Number Publication Date
FR2881957A1 FR2881957A1 (fr) 2006-08-18
FR2881957B1 true FR2881957B1 (fr) 2008-08-08

Family

ID=35045407

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0501580A Expired - Fee Related FR2881957B1 (fr) 2005-02-16 2005-02-16 Comprimes comprenant une substance biologiquement active et un excipient

Country Status (7)

Country Link
US (1) US7892576B2 (fr)
EP (1) EP1853236A1 (fr)
JP (1) JP2008530175A (fr)
AR (1) AR056268A1 (fr)
FR (1) FR2881957B1 (fr)
TW (1) TW200640442A (fr)
WO (1) WO2006087312A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2876999B1 (fr) * 2004-10-25 2007-11-09 Solvay Suspensions contenant des particules de carbonate de calcium presentant un etat d'agregation controle
EP1657278A1 (fr) 2004-11-12 2006-05-17 SOLVAY (Société Anonyme) Particules enrobées de carbonate de calcium avec surface spécifique élevée
CN101090949B (zh) 2004-12-22 2013-06-05 索尔维公司 碱土金属碳酸盐的耐酸粒子
EP1746073A1 (fr) * 2005-07-20 2007-01-24 SOLVAY (Société Anonyme) Procédé de préparation de solides par précipitation, dispersions et solides obtenues et leur utilisation comme additif
CA2752069A1 (fr) * 2009-02-12 2010-08-19 Aduro Material Ab Composition comprenant un support biodegradable pour commande de l'administration de medicament
CA2756428A1 (fr) * 2009-03-27 2010-09-30 Mamoru Fukuda Preparation a liberation prolongee de type matrice contenant un additif basique
CN102481257B (zh) * 2009-04-24 2014-08-13 Omya国际股份公司 用于控释活性成分的颗粒材料
JP2011057586A (ja) * 2009-09-08 2011-03-24 Kyorin Pharmaceutical Co Ltd ｐＨ非依存性マトリックス型徐放性製剤
HUE025008T2 (en) * 2012-10-12 2016-04-28 Omya Int Ag Gastro-reactive pharmaceutical composition and delivery systems and method for their preparation using functionalized calcium carbonate
EP3034070A1 (fr) * 2014-12-18 2016-06-22 Omya International AG Procédé pour la production d'un système d'administration pharmaceutique
EP3069713A1 (fr) 2015-03-20 2016-09-21 Omya International AG Forme posologique dispersible
EP3176222A1 (fr) * 2015-12-01 2017-06-07 Omya International AG Procédé de production de granules comprenant du carbonate de calcium traité par réaction en surface

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2789938A (en) * 1952-11-24 1957-04-23 Merck & Co Inc Method of producing a diuretic effect with p-carboxybenzenesulfonamide
US3475419A (en) * 1967-12-06 1969-10-28 Sterling Drug Inc 17 - hydroxy - 3 - oxyestra - 1,3,5(10) - triene-17alpha-carboxaldehydes and derivatives
US3532711A (en) * 1969-02-17 1970-10-06 Sterling Drug Inc Tertiary-amino-lower-alkoxy-9-r-9-hydroxyxanthenes and thioxanthenes
ZA761305B (en) * 1975-03-17 1977-02-23 Hoffmann La Roche Sustained release formulation
US4744987A (en) * 1985-03-08 1988-05-17 Fmc Corporation Coprocessed microcrystalline cellulose and calcium carbonate composition and its preparation
JPS62277322A (ja) * 1986-02-13 1987-12-02 Takeda Chem Ind Ltd 安定化された腸溶性抗潰瘍固形組成物
US5433959A (en) * 1986-02-13 1995-07-18 Takeda Chemical Industries, Ltd. Stabilized pharmaceutical composition
CA1327010C (fr) * 1986-02-13 1994-02-15 Tadashi Makino Compositions pharmaceutiques contenant un compose anti-ulcereux de type benzimidazole et sa production
JPH0798742B2 (ja) * 1986-07-03 1995-10-25 ゼリア新薬工業株式会社 徐放性製剤組成物
US4755987A (en) * 1987-06-05 1988-07-05 Bell Communications Research, Inc. High speed scrambling at lower clock speeds
JP2538134B2 (ja) * 1991-04-08 1996-09-25 田辺製薬株式会社 徐放性製剤およびその製造法
CA2067975C (fr) * 1991-05-20 2003-01-14 Cynthia M. Blase Comprime d'aspirine a matrice tamponnee
JP2525975B2 (ja) * 1991-09-06 1996-08-21 備北粉化工業株式会社 低分子量キトサン含有植物機能調節用組成物
US5741471A (en) * 1995-12-05 1998-04-21 Minerals Technologies Inc. Process for the preparation of discrete particles of calcium carbonate
GB9600390D0 (en) 1996-01-09 1996-03-13 Univ London Pharmacy Preparation of tablets
RU2189227C2 (ru) * 1996-07-12 2002-09-20 Дайити Фармасьютикал Ко., Лтд. Быстро распадающиеся прессованные в формах материалы и способ их получения
US20030161894A1 (en) * 2001-09-05 2003-08-28 3P Technologies Ltd. Precipitated aragonite and a process for producing it
JP2002348234A (ja) 2001-05-28 2002-12-04 Purotekku:Kk 薬物封入無機物微粒子、その製造法及び薬物封入無機物微粒子製剤
FR2826950B1 (fr) * 2001-07-04 2004-09-10 Solvay Procede pour l'obtention de particules de carbonate de calcium precipite structurees a l'echelle nanometrique
FR2862308B1 (fr) * 2003-11-14 2008-02-15 Solvay Procede de fabrication d'une resine synthetique et resine synthetique obtenue au moyen de ce procede
FR2876999B1 (fr) 2004-10-25 2007-11-09 Solvay Suspensions contenant des particules de carbonate de calcium presentant un etat d'agregation controle
EP1657278A1 (fr) 2004-11-12 2006-05-17 SOLVAY (Société Anonyme) Particules enrobées de carbonate de calcium avec surface spécifique élevée
CN101090949B (zh) 2004-12-22 2013-06-05 索尔维公司 碱土金属碳酸盐的耐酸粒子
WO2006134080A1 (fr) 2005-06-15 2006-12-21 Solvay (Société Anonyme) Utilisation de particules de carbonate de calcium dans la production de materiaux de construction
EP1746073A1 (fr) 2005-07-20 2007-01-24 SOLVAY (Société Anonyme) Procédé de préparation de solides par précipitation, dispersions et solides obtenues et leur utilisation comme additif
ITMI20051464A1 (it) 2005-07-28 2007-01-29 Macri Chemicals Srl Composizioni di vernici e loro impiego per il rivestimento di superfici di substrati
FR2891546B1 (fr) 2005-10-04 2010-09-03 Solvay Utilisation de particules de carbonate de calcium dans des compositions polymeriques transparentes, compositions polymeriques transparentes et procede de fabrication de ces compositions

Also Published As

Publication number Publication date
JP2008530175A (ja) 2008-08-07
FR2881957A1 (fr) 2006-08-18
EP1853236A1 (fr) 2007-11-14
US20080131506A1 (en) 2008-06-05
WO2006087312A1 (fr) 2006-08-24
US7892576B2 (en) 2011-02-22
AR056268A1 (es) 2007-10-03
TW200640442A (en) 2006-12-01

Similar Documents

Publication Publication Date Title
FR2881957B1 (fr) Comprimes comprenant une substance biologiquement active et un excipient
HRP20181819T1 (hr) Formulacija krutog farmaceutskog oblika doziranja koja sadrži lopinavir
FR14C0069I2 (fr) Composition pharmaceutique comprenant le lurasidone
ITBO20050123A1 (it) Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
NO20075628L (no) Farmasøytiske formuleringer
DK1753406T4 (da) Overtrukket tabletformulering og fremgangsmåde
DE60316552D1 (de) Tablette mit hohem wirkstoffgehalt
DK1876897T3 (da) Aktivstofkombinationer
MA28489B1 (fr) Preparations pharmaceutiques
DK1962932T3 (da) Indretning til medikamentdosering
ATE447991T1 (de) Arzneimittelabgabevorrichtung
ITMI20050729A1 (it) Nuova formulazione biologicamente attiva
DK1957073T3 (da) Lægemiddel
FR18C1032I2 (fr) Anticorps anti-fgf23 et composition pharmaceutique le comprenant
IS7571A (is) Ný lífeðlisfræðilega virk efni
DE602004016967D1 (de) Flüssige pharmazeutische palonosetronformulierungen
IL184067A0 (en) Tablet formulation for sustained drug-release
DK2918286T3 (da) En farmaceutisk formulering
MA28603B1 (fr) Composition pharmaceutique antimycobacterienne
MA28846B1 (fr) Composition biologiquement active
FR2888041B1 (fr) Plaque active d'ecran plat
EP1941054A4 (fr) Mise au point d'un anthelminthique et/ou d'un insecticide
UA10369S (uk) Таблетка фармацевтична
ATA16852004A (de) Tablette
FR2892698B1 (fr) Quille active

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20121031